Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Leukemia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Leukemia|May 23, 2001
Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?R Storb
Leukemia|August 1, 1993
Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantationR Storb
Leukemia|August 1, 1993
Stem cell regulation and engraftmentR Storb
Leukemia|April 18, 2002
Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemiaR Storb
Leukemia|February 1, 1991
Biochemical characterization of a unique canine myeloid antigenB M Sandmaier, F G Schuening, J A Bianco, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Leukemia|May 23, 2001
Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?R Storb
Leukemia|August 1, 1993
Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantationR Storb
Leukemia|August 1, 1993
Stem cell regulation and engraftmentR Storb
Leukemia|April 18, 2002
Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemiaR Storb
Leukemia|February 1, 1991
Biochemical characterization of a unique canine myeloid antigenB M Sandmaier, F G Schuening, J A Bianco, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
Pageof 1